PROGRAM CANCER AGAINST ITSELF
Live / Allowed — Publication / registration review complete (as of 28 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 12 Mar 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99699133
- Mark type
- Stylized text
- Filed
- 12 Mar 2026
- Published for opposition
- 15 Sept 2026
- Attorney of record
- Ted D. Karr
Goods and services
- Class 005 — Pharmaceuticals: Products for the prevention of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the localization of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for localization of cancer; Products for the therapy of cancer in humans, namely, pharmaceutical products to express a treatment agent for treating cancer; Products for the prevention of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the therapy of cancer in animals, namely, pharmaceutical products to express a treatment agent for treating cancer
- Class 044 — Medical, beauty and agricultural services: Medical services for the prevention of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the localization of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for the localization of cancer; Medical services for the therapy of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for treating cancer; Medical services for the prevention of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the therapy of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for the treatment of cancer
Owner
- Earli Inc., Redwood City, CA, US
Prosecution history
- 09 Sept 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Aug 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Jun 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Jun 2026 — NON-FINAL ACTION E-MAILED
- 28 Jun 2026 — NON-FINAL ACTION WRITTEN
- 22 Jun 2026 — ASSIGNED TO EXAMINER
- 12 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 12 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Mar 2026 — NEW APPLICATION ENTERED